Year: 2022

Blue Water Vaccines Reports Third Quarter 2022 Financial Results and Recent Business Highlights; Announces 5 Million Share Repurchase Program

Written by Customer Service on November 10, 2022. Posted in Earnings Releases And Operating Results.

Closed private placement in August 2022, with net proceeds of approximately $8.7 million Announced plans to evaluate efficacy of BWV-201 for protection against non-invasive pneumococcal pneumonia in children and adults Board of Directors authorized a 5 million share repurchase program in November 2022 $29.1 million in cash as of September 30, 2022CINCINNATI, Nov. 10, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), today announced its financial results for the third quarter ended September 30, 2022 and provided an update on recent business developments and progress. Blue Water Vaccines is a pre-clinical stage biotechnology company developing vaccines against multiple infectious diseases, including acute otitis media (AOM) and pneumonia from Streptococcus pneumoniae colonization,...

Global Spinal Cord Stimulation Market to Worth $3.63 Billion by 2028 | AI in is Becoming Mainstream in Spinal Cord Stimulation Devices

Written by Customer Service on November 10, 2022. Posted in Mergers And Acquisitions.

Global spinal cord stimulation market to reach valuation of $3.63 billion by 2028 from $2.12 billion in 2021. The market is expected to grow at a healthy CAGR of 8% during the forecast period, 2022–2028. Westford, USA, Nov. 10, 2022 (GLOBE NEWSWIRE) — As the population ages, the demand for spinal cord stimulation (SCS) is expected to grow. SCS is a treatment for chronic pain, and can be an effective alternative to surgery or other invasive treatments. A recent study by SkyQuest on the US spinal cord stimulation market found that the number of SCS procedures performed in the United States has grown steadily over the past decade, with an estimated 28,000 procedures being performed in 2021. This represents a nearly tree-fold increase from the 8,500 procedures performed in 2010. The study also found that the majority of SCS procedures...

Orbit International Corp. Reports 2022 Third Quarter Results

Written by Customer Service on November 10, 2022. Posted in Earnings Releases And Operating Results.

Third Quarter 2022 Net Loss of $303,000 ($0.09 loss per share) v. Net Income of $681,000 ($0.20 per diluted share) in Prior Year Period Third Quarter 2022 EBITDA, As Adjusted, was a loss of $232,000 ($0.07 loss per share) v. $736,000 ($0.21 per diluted share) in Prior Year Period Nine Months 2022 Net Loss of $249,000 ($0.07 loss per share) v. Net Income of $3,042,000 ($0.87 per diluted share) in Prior Year Period. Prior Period Includes $1,618,000 ($0.46 per diluted share) of PPP Loan Forgiveness. Exclusive of PPP Loan Forgiveness, Prior Period Net Income was $1,424,000 ($0.41 per diluted share) Nine Months 2022 EBITDA, As Adjusted, was a loss of $63,000 ($0.02 loss per share) v. $3,255,000 ($0.93 per diluted share) in Prior Year Period. Exclusive of PPP Loan Forgiveness, Prior Period EBITDA, As Adjusted was $1,637,000 ($0.47 per diluted...

Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2022 and Provides Corporate Update

Written by Customer Service on November 10, 2022. Posted in Earnings Releases And Operating Results.

–FemaSeed® de novo trial enrollment accelerates with strategic trial design update to focus on male factor infertility– —Company remains on track to file an Investigational Device Exemption (IDE) for a pivotal trial to support a Pre-Market Authorization (PMA) for FemBloc® in Q1 2023– –FemCerv® now commercially available with FemCath™ launch expected by year-end– ATLANTA, Nov. 10, 2022 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women’s needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced financial results for the third quarter and nine months ended September 30, 2022 and provided a corporate update. “We’ve hit multiple company milestones...

Global Neuroprosthetic Market to Surpass Valuation of $21.5 Billion by 2028 | Brainwave Implants and Cochlear attract Highest Revenue Opportunities

Written by Customer Service on November 10, 2022. Posted in Mergers And Acquisitions.

Global neuroprosthetic market is expected to grow from $9.61 billion in 2021 to $21.5 billion by 2028, at a compound annual growth rate (CAGR) of 12.2%. Westford, USA, Nov. 10, 2022 (GLOBE NEWSWIRE) — Neuroprosthetic is a rapidly growing field with immense potential. Neuroprosthetic devices are used to restore or improve function in individuals with neurodegenerative disorders, spinal cord injuries, and other conditions. This growth of the global neuroprosthetic market is driven by factors such as the increasing prevalence of neurological disorders, the development of technologically advanced the devices, and the rising number of clinical trials for neuroprosthetic devices. One of the most common neurodegenerative diseases is Alzheimer’s disease, which affects an estimated 5.7 million Americans over the age of 65. In fact,...

Global Infusion Pump Market Sales Revenue to Exceed $15.81 Billion by 2028 | Reimbursement Policies and Regulations to Play Key Role Market Growth

Written by Customer Service on November 10, 2022. Posted in Mergers And Acquisitions.

Global infusion pump market was valued at USD 9.67 billion in 2021 and it is expected to reach at USD 15.81 billion by 2028, at a CAGR of 7.3% over the forecast period (2022-2028). Westford, USA, Nov. 10, 2022 (GLOBE NEWSWIRE) — An infusion pump is a medical device that delivers fluids, such as nutrients and medications, into the body through a catheter or needle. Infusion pumps are used to treat a variety of conditions, including diabetes, cancer, and pain management. The infusion pump market growth is primarily driven by the rising prevalence of chronic diseases, growing demand for homecare services, and advancements in technology. According to the World Health Organization (WHO), chronic diseases are responsible for approximately 60% of all deaths globally. These diseases include cardiovascular diseases, cancer, chronic respiratory...

Mobile Gaming Market to Exceed Valuation of $214.61 Billion By 2028 | Mobile Gaming Generates Over 60% Revenue of Global Video Gaming Market

Written by Customer Service on November 10, 2022. Posted in Mergers And Acquisitions.

Global mobile gaming market size was valued at USD 97.81 billion in 2021, and it is expected to reach a value of USD 214.61 billion by 2028, at a CAGR of more than 11.88% over the forecast period (2022-2028). Westford, USA, Nov. 10, 2022 (GLOBE NEWSWIRE) — Over the past few years, the mobile gaming market has exploded in popularity. There are now more than 3 billion active mobile gamers worldwide, and this number is only expected to grow. However, as the market matures, it faces a number of challenges. These include everything from the ongoing fight against piracy to the need to better monetize free-to-play games. In terms of future trends, SkyQuest believes that cloud gaming will have a significant impact on the market. Cloud gaming services allow gamers to play games without needing to download them onto their device, making...

IoT In Healthcare Market to Hit Sales of $332.52 Billion by 2028 | IoT Market to Surpass Valuation of $2412.49 Billion

Written by Customer Service on November 10, 2022. Posted in Mergers And Acquisitions.

IoT in healthcare market was valued at USD 87.06 Billion in 2021, and it is expected to reach a value of USD 332.52 Billion by 2028, at a CAGR of 21.10% over the forecast period (2022-2028). Westford, USA, Nov. 10, 2022 (GLOBE NEWSWIRE) — By 2025, the number of internet-connected devices is expected to reach 27 billion. of these, 2.3 billion will be used in healthcare, according to a report from SkyQuest Technology. IoT in healthcare market is one of the most promising and rapidly growing areas in healthcare technology. Hospitals and other care providers are starting to see the potential of IoT to transform the way they provide care, improve patient outcomes, and lower costs. There are a number of factors driving the demand for IoT in healthcare. One is the increasing prevalence of chronic conditions, which require ongoing management...

Pineapple Energy Acquires New York-based SUNation Energy

Written by Customer Service on November 10, 2022. Posted in Mergers And Acquisitions.

Acquisition Expected to Triple Annual RevenueStrong Fit with Pineapple’s Customer-centric Model MINNETONKA, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (“Pineapple,” “Pineapple Energy” or the “Company”), a leading provider of sustainable solar energy and back-up power to households and small businesses, today announced the acquisition of SUNation Energy (“SUNation”), a New York-based installer of solar and battery energy storage systems for residential and small commercial customers. The transaction closed on November 9, 2022. SUNation has served Long Island for 19 years, offering a range of solar energy solutions including residential, commercial, battery storage, and roofing, and currently services over 12,000 PV systems. Over the course of almost 8,000 projects since inception, SUNation has installed over 275,000...

Nanox Announces Third Quarter 2022 Financial Results and Provides Business Update

Written by Customer Service on November 10, 2022. Posted in Earnings Releases And Operating Results.

Reports progress towards global supply chain development Ended the third quarter of 2022 with cash, cash equivalents and marketable securities of $117.1 million Management to host conference call and webcast Thursday, November 10, 2022 at 8:30 AM ET NEVE ILAN, Israel, Nov. 10, 2022 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the third quarter ended September 30, 2022 and provided a business update. Third Quarter 2022 Highlights and Recent Developments:Generated $2.4 million in revenue in the third quarter of 2022 compared to $2.2 million in the second quarter of 2022 and $1.8 million in the first quarter of 2022.Submitted a 510(k) premarket notification to the U.S. Food and Drug Administration as part of the Company’s...

Year: 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals